Other
Number of development candidates
Moderna Number of development candidates decreased by 16.7% to $25 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 19.4%, from $31 to $25.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ2 2023
Last reportedQ1 2026May 1, 2026
Metric ID:
other_number_of_development_candidatesHistorical Data
9 periods
| Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | 45 | 41 | 40 | 40 | 36 | 31 | 30 | 30 | 25 |
| QoQ Change | — | -8.9% | -2.4% | +0.0% | -10.0% | -13.9% | -3.2% | +0.0% | -16.7% |
| YoY Change | — | — | — | -11.1% | -12.2% | -22.5% | -25.0% | -16.7% | -19.4% |
Range25 – 45
CAGR-25.5%
Avg YoY Growth-17.8%
Median YoY Growth-18.0%
Frequently Asked Questions
- What is Moderna's number of development candidates?
- Moderna (MRNA) reported number of development candidates of $25 in Q1 2026.
- How has Moderna's number of development candidates changed year-over-year?
- Moderna's number of development candidates decreased by 19.4% year-over-year, from $31 to $25.